Equities

IRIDEX Corp

IRIX:NAQ

IRIDEX Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.88
  • Today's Change0.47 / 33.33%
  • Shares traded299.36k
  • 1 Year change-8.29%
  • Beta0.7567
Data delayed at least 15 minutes, as of Nov 13 2024 20:14 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

IRIDEX Corporation is an ophthalmic medical technology company. It develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.

  • Revenue in USD (TTM)49.70m
  • Net income in USD-10.86m
  • Incorporated1995
  • Employees111.00
  • Location
    IRIDEX Corp1212 Terra Bella AveMOUNTAIN VIEW 94043-1824United StatesUSA
  • Phone+1 (650) 940-4700
  • Fax+1 (650) 940-4710
  • Websitehttps://www.iridex.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
bioAffinity Technologies Inc7.32m-8.74m19.81m75.00--4.28--2.71-0.9007-0.90070.74390.29890.9422236.818.6897,545.07-112.51---140.58--35.47---119.41--1.14-296.510.234--52,660.42--2.66------
Neuronetics Inc72.07m-32.47m20.91m203.00--1.07--0.2902-1.10-1.102.450.64330.73092.314.76355,000.00-32.93-28.02-42.47-34.7375.9175.73-45.06-51.042.37-3.920.755--9.426.2218.76--18.57--
BioNano Genomics Inc36.58m-204.10m21.37m344.00--0.2334--0.5841-5.15-5.150.74961.140.18261.005.28106,334.30-101.86-56.82-123.67-67.8328.9725.38-557.98-505.761.11-61.510.0455--29.9024.65-75.34--38.51--
Retractable Technologies Inc38.25m-18.10m21.55m148.00--0.2529--0.5634-0.6046-0.60461.282.850.22021.446.42258,468.00-10.2812.45-10.7914.5119.1940.82-46.7118.096.54-2.860.016---54.025.55-249.46--17.42--
Neuraxis Inc2.27m-15.26m21.62m19.00------9.54-3.09-3.090.4039-0.76861.096.6311.80119,318.90-731.17------87.29---672.94--0.2724-19.01-----8.37---163.78------
Femasys Inc950.09k-16.69m22.90m32.00--2.04--24.10-0.8468-0.84680.04720.50600.05490.34387.6529,690.31-96.51---108.58--65.67---1,756.83--5.93-77.250.2972---11.13---25.04------
IRIDEX Corp49.70m-10.86m23.46m111.00--5.46--0.472-0.6679-0.66793.060.25811.462.667.84447,747.80-31.84-19.54-54.55-27.4640.4442.67-21.85-15.450.8599--0.00---8.964.02-26.81---24.35--
United Health Products Inc0.00-1.84m24.15m6.00---------0.0075-0.00750.00-0.00810.000.00--0.00-662.95-6,446.86------53.19---132,561.200.0126-15.12-----100.00---55.45------
Vaso Corp80.33m2.26m24.38m300.009.010.91237.780.30350.01540.01540.45710.15241.1022.599.62267,766.703.107.605.0416.6261.2058.392.815.821.48--0.0028--2.181.84-57.46---22.33--
Inspira Technologies Oxy BHN Ltd0.00-11.29m24.71m37.00--3.66-----0.9549-0.95490.000.36660.00----0.00-88.60-114.98-108.36-159.56------------0.00------24.64------
Spectral AI Inc22.53m-20.24m25.09m78.00------1.11-1.48-1.481.55-0.24221.68--11.54288,859.00-150.54---954.46--45.12---89.85--0.7066--2.14---28.82---616.14------
Know Labs Inc0.00-16.34m26.14m15.00---------0.2204-0.22040.00-0.05330.00----0.00-442.53-209.16---1,087.76-------1,302.62---15.986.21---100.00---1.85---3.64--
Positron Corp1.24m-1.27m26.19m22.00------21.17-0.0897-0.08970.0876-0.11090.59762.296.56---61.35-224.13----32.989.85-102.67-201.870.0638-------10.060.275163.63--4.36--
Neuroone Medical Technologies Corp3.96m-12.10m27.42m16.00--8.23--6.92-0.4916-0.49160.15930.10820.74281.6919.31247,702.50-226.84-172.88-334.70-274.7429.60---305.37-674.971.36--0.00--62.66---18.60------
Movano Inc852.00k-26.83m27.90m30.00--1.66--32.75-6.79-6.790.19692.540.0444--3.3828,400.00-139.74-151.50-176.37-188.58-87.21---3,149.06--5.23--0.0025------3.45--4.24--
Data as of Nov 13 2024. Currency figures normalised to IRIDEX Corp's reporting currency: US Dollar USD

Institutional shareholders

18.09%Per cent of shares held by top holders
HolderShares% Held
Paragon JV Partners LLCas of 30 Jun 20241.00m6.01%
The Vanguard Group, Inc.as of 30 Jun 2024557.13k3.35%
AMH Equity Ltd.as of 30 Sep 2024501.12k3.01%
Renaissance Technologies LLCas of 30 Jun 2024404.96k2.43%
Geode Capital Management LLCas of 30 Jun 2024129.09k0.78%
ARS Investment Partners LLCas of 30 Sep 2024113.57k0.68%
Long Focus Capital Management LLCas of 30 Jun 2024100.00k0.60%
Bridgeway Capital Management LLCas of 30 Jun 202477.10k0.46%
Apexium Financial LPas of 30 Sep 202465.70k0.40%
Susquehanna Financial Group LLLPas of 30 Jun 202460.86k0.37%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.